外来睡眠ポリグラフ（PSG）システムの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

外来睡眠ポリグラフ（PSG）システムの世界市場規模は、2024年の4億3,395万米ドルから2033年には7億7,724万米ドルに成長し、2026～2033年の予測期間中に6.69％の堅調な年間平均成長率（CAGR）を示すと予測されます。

外来睡眠ポリグラフ（PSG）システム市場は、睡眠障害の有病率の増加と在宅診断ソリューションの需要の高まりに牽引され、ダイナミックな成長局面を迎えています。医療システムがより患者中心のモデルへと進化するにつれ、外来PSGシステムの利便性とアクセシビリティはますます魅力的になってきています。これらのシステムは、睡眠時無呼吸症候群のような疾患の診断を容易にするだけでなく、患者が自宅で快適に検査を受けられるようにすることで、コンプライアンスを強化し、医療施設の負担を軽減します。

技術の進歩はこの市場の進化の最前線にあり、ウェアラブルデバイスやモバイルヘルスアプリケーションの革新は、睡眠検査の精度と効率を高めています。人工知能と機械学習アルゴリズムのPSGシステムへの統合は、データ分析をさらに革新し、臨床医が複雑なデータセットから実用的な洞察を導き出せるようにします。この技術的相乗効果により診断プロセスが合理化され、タイムリーな介入と患者の転帰改善につながると期待されます。

さらに、睡眠の健康の重要性に対する意識の高まりが市場拡大の触媒となっています。公衆衛生キャンペーンや教育イニシアティブが睡眠障害への理解を深め、個人が積極的に診断サービスを受けるよう促しています。医療プロバイダーが健康全般における睡眠の重要性をますます認識するようになり、外来PSGシステムの需要が急増すると予想されます。この進化する情勢において、利害関係者は外来PSGシステム市場が提供する機会を活用するのに有利な立場にあり、睡眠の健康管理を強化する革新的なソリューションへの道を開きます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するためのいくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 外来睡眠ポリグラフ（PSG）システム産業分析

• イントロダクション-市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 産業動向
• ポーターのファイブフォース分析
• 市場の魅力分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原料分析
  • 原料リスト
  • 原料メーカー一覧
  • 主要原料の価格動向
• 潜在的バイヤーリスト
• マーケティングチャネル
  • 直接マーケティング
  • 間接マーケティング
  • マーケティングチャネル発展動向

第5章 外来睡眠ポリグラフ（PSG）システムの世界市場分析：製品別

• 製品別概要
• 製品別過去・予測データ分析
• 12チャネル以下
• 24チャネル以下
• 32チャネル以下
• 32チャネル以上

第6章 外来睡眠ポリグラフ（PSG）システムの世界市場分析：用途別

• 用途別概要
• 用途別過去・予測データ分析
• 閉塞性睡眠
• 無呼吸ナルコレプシー
• 慢性不眠症
• その他

第7章 外来睡眠ポリグラフ（PSG）システムの世界市場分析：エンドユーザー別

• エンドユーザー別概要
• エンドユーザー別過去・予測データ分析
• 病院
• 睡眠ラボ
• 在宅医療

第8章 外来睡眠ポリグラフ（PSG）システムの世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米：国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • 欧州：セグメント別
  • 欧州：国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他の欧州
• アジア太平洋売上分析
  • 概要、実績と予測
  • アジア太平洋：セグメント別
  • アジア太平洋：国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他のアジア太平洋
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • ラテンアメリカ：セグメント別
  • ラテンアメリカ：国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他のラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • 中東・アフリカ：セグメント別
  • 中東・アフリカ：国別一覧
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他の中東・アフリカ

第9章 外来睡眠ポリグラフ（PSG）システム企業の競合情勢

• 外来睡眠ポリグラフ（PSG）システム市場競争
• パートナーシップ/提携/合意
• 合併と買収
• 新製品の発売
• その他の開発

第10章 企業プロファイル

• 上位企業の市場シェア分析
• 市場集中度
• Compumedics Limited
• Nihon Kohden Corporation
• Koninklijke Philips N.V.
• SOMNOmedics GmbH
• Cadwell Industries Inc.
• Natus Medical Incorporated
• LoWenstein Medical Technology GmbH+Co. KG.
• Nox Medical
• Neurosoft

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product (USD MN)
• Up to 12 Channel PSG Systems Market Sales By Geography (USD MN)
• Up to 24 Channel PSG Systems Market Sales By Geography (USD MN)
• Up to 32 Channel PSG Systems Market Sales By Geography (USD MN)
• Above 32 Channel PSG Systems Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Obstructive Sleep Market Sales By Geography (USD MN)
• Apnea Narcolepsy Market Sales By Geography (USD MN)
• Chronic Insomnia Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By End-user (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Sleep Laboratories Market Sales By Geography (USD MN)
• Home Care Settings Market Sales By Geography (USD MN)
• Global Ambulatory Polysomnography (PSG) System Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Ambulatory Polysomnography (PSG) System Report
• Market Research Process
• Market Research Methodology
• Global Ambulatory Polysomnography (PSG) System Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End-user
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Up to 12 Channel PSG Systems Market Sales By Geography (USD MN)
• Up to 24 Channel PSG Systems Market Sales By Geography (USD MN)
• Up to 32 Channel PSG Systems Market Sales By Geography (USD MN)
• Above 32 Channel PSG Systems Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Obstructive Sleep Market Sales By Geography (USD MN)
• Apnea Narcolepsy Market Sales By Geography (USD MN)
• Chronic Insomnia Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By End-user (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Sleep Laboratories Market Sales By Geography (USD MN)
• Home Care Settings Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Global Ambulatory Polysomnography (PSG) System Market size is anticipated to grow from USD 433.95 Million in 2024 to USD 777.24 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.69% during the forecast period of 2026 to 2033.

The ambulatory polysomnography (PSG) system market is entering a dynamic phase of growth, driven by the increasing prevalence of sleep disorders and the rising demand for home-based diagnostic solutions. As healthcare systems evolve towards more patient-centric models, the convenience and accessibility of ambulatory PSG systems are becoming increasingly appealing. These systems not only facilitate the diagnosis of conditions such as sleep apnea but also empower patients to undergo testing in the comfort of their homes, thereby enhancing compliance and reducing the burden on healthcare facilities.

Technological advancements are at the forefront of this market's evolution, with innovations in wearable devices and mobile health applications enhancing the accuracy and efficiency of sleep studies. The integration of artificial intelligence and machine learning algorithms into PSG systems is further revolutionizing data analysis, enabling clinicians to derive actionable insights from complex datasets. This technological synergy is expected to streamline the diagnostic process, leading to timely interventions and improved patient outcomes.

Moreover, the growing awareness of the importance of sleep health is catalyzing market expansion. Public health campaigns and educational initiatives are fostering a greater understanding of sleep disorders, prompting individuals to seek diagnostic services proactively. As healthcare providers increasingly recognize the significance of sleep in overall health, the demand for ambulatory PSG systems is anticipated to surge. In this evolving landscape, stakeholders are well-positioned to capitalize on the opportunities presented by the ambulatory PSG system market, paving the way for innovative solutions that enhance sleep health management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

• Up to 12 Channel PSG Systems
• Up to 24 Channel PSG Systems
• Up to 32 Channel PSG Systems
• Above 32 Channel PSG Systems

By Application

• Obstructive Sleep
• Apnea Narcolepsy
• Chronic Insomnia
• Others

By End-user

• Hospitals
• Sleep Laboratories
• Home Care Settings
• COMPANIES PROFILED
• Compumedics Limited
• Nihon Kohden Corporation
• Koninklijke Philips N.V.
• SOMNOmedics GmbH
• Cadwell Industries Inc.
• Natus Medical Incorporated
• Lowenstein Medical Technology GmbH + Co. KG.
• Nox Medical
• Neurosoft
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Up to 12 Channel PSG Systems Historic and Forecast Sales By Regions
• 5.4. Up to 24 Channel PSG Systems Historic and Forecast Sales By Regions
• 5.5. Up to 32 Channel PSG Systems Historic and Forecast Sales By Regions
• 5.6. Above 32 Channel PSG Systems Historic and Forecast Sales By Regions

6. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Obstructive Sleep Historic and Forecast Sales By Regions
• 6.4. Apnea Narcolepsy Historic and Forecast Sales By Regions
• 6.5. Chronic Insomnia Historic and Forecast Sales By Regions
• 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-user
• 7.2. Historical and Forecast Data Analysis By End-user
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Sleep Laboratories Historic and Forecast Sales By Regions
• 7.5. Home Care Settings Historic and Forecast Sales By Regions

8. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM COMPANIES

• 9.1. Ambulatory Polysomnography (PSG) System Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEM INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Compumedics Limited
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Nihon Kohden Corporation
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Koninklijke Philips N.V.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. SOMNOmedics GmbH
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Cadwell Industries Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Natus Medical Incorporated
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. LöWenstein Medical Technology GmbH + Co. KG.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Nox Medical
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Neurosoft
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies